Results 181 to 190 of about 28,497 (308)
Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 1, July 2026.ABSTRACT Dopaminergic medication used in disorders like Parkinson's disease (PD) and restless legs syndrome can cause impulsive‐compulsive behaviour (ICB), often with strong negative effects on patients' quality of life. This narrative review presents translational evidence on iatrogenic ICB, taking findings from epidemiological, clinical, neuroimaging
Mirjam Wolfschlag +7 more
wiley +1 more source
Repetitive transcranial magnetic stimulation for post stroke rehabilitation-a single center community experience. [PDF]
Front NeurolJacques FH +4 more
europepmc +1 more source
Human Brain Mapping, Volume 47, Issue 9, June 15, 2026.Unilateral prefrontal TILS reliably increases ipsilateral cytochrome‐c‐oxidase and oxygenated hemoglobin, demonstrating dose‐dependent metabolic efficacy without adverse effects. Contralateral responses are asymmetric: changes emerge later and differ by stimulation side, with stronger right‐hemisphere effects after left‐sided TILS, suggesting ...
Patrick O'Connor +4 more
wiley +1 more source
Correction: Effects of high-frequency repetitive transcranial magnetic stimulation combined with acupuncture on central pain and mood. [PDF]
Front PsychiatryWu X, Li B, Xiang T, Fan X.
europepmc +1 more source
Emerging directions in tauopathy research
Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.Abstract The Tau Global Conference 2025, hosted by the Alzheimer's Association, CurePSP, and the Rainwater Charitable Foundation, convened international experts from academia, industry, government, and philanthropy to explore advances and challenges in tauopathy research. The meeting highlighted progress across tau biology, including emerging models of
Luc Buée +41 more
wiley +1 more source
Prolonged P3 latency predicts clinical response to repetitive transcranial magnetic stimulation in tinnitus. [PDF]
Clin Neurophysiol PractDing ZL +5 more
europepmc +1 more source
Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.Abstract Patients with atypical variants of Alzheimer's disease (AD) often present at a younger age with predominantly non‐amnestic impairments and a more aggressive disease course. Historically, individuals with atypical presentations have not been included in large‐scale clinical trials, which typically focus on late‐onset, sporadic amnestic ...
Nick Corriveau‐Lecavalier +36 more
wiley +1 more source
The include network: Advancing cross‐linguistic equity in brain health research
Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.Abstract Speech and language measures are increasingly recognized as sensitive, scalable, non‐invasive markers of diverse brain disorders. Yet, current research is overwhelmingly English‐centric, neglecting the world's vast linguistic diversity and undermining these markers’ global applicability.
Adolfo M. García +13 more
wiley +1 more source
Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.Abstract Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder driven by intersecting pathological processes. Persistent attrition in AD drug‐development pipelines highlights the limited clinical impact of single‐target therapies and has increased interest in multi‐target approaches acting on shared biological hubs.
Humberto Martínez‐Orozco +4 more
wiley +1 more source
Effects of high-frequency repetitive transcranial magnetic stimulation combined with acupuncture on central pain and mood. [PDF]
Front PsychiatryWu X, Li B, Xiang T, Fan X.
europepmc +1 more source